$SJM

J.M. Smucker Q4 Earnings Call Highlights

J.M. Smucker said it expects profit improvement in coffee as the commodity environment moderates, while it is cautious about forecasting volume response to lower prices because consumers remain guarded. For fiscal 2027, it expects net sales roughly flat in Q1, with coffee deflation impacting more in Q2+. Uncrustables hit $1B sales; Smucker targets mid-single-digit growth in fiscal 2027. It generated $1.2B free cash flow in 2026, repaying $700M+ debt, and targets at least $1B FCF in 2027 while as

Original reporting
Published Jun 11, 2026, 1:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 1:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
J.M. Smucker Q4 Earnings Call Highlights — source image
Decision brief

The 30-second read

$SJMNeutralMed
01

Why it matters

Traders can update models for FY27: Q1 net sales roughly flat, green coffee deflation impacts more in Q2+, Uncrustables mid-single-digit growth in FY27, marketing spend ~5.7% of net sales, and a 10% tariff assumption with uncertain refund timing.

02

Market read

Management provided concrete outlook parameters (margin range timing, volume caution, Uncrustables growth rate, tariff level, and leverage path) that can drive earnings estimate revisions.

03

What to watch

Tariff refunds are pursued but excluded from guidance; if refunds are delayed or smaller than hoped, leverage/cash deployment expectations could face incremental pressure.

Relevance 7/10Novelty 5/10Timing: Ahead of next earnings/quarter modeling for Q1 flat sales and Q2+ coffee deflation.

Background

The piece summarizes management commentary from Smucker’s Q4 earnings call, focusing on coffee economics, Uncrustables growth, and segment profitability drivers (spreads/pet/sweet baked snacks).

Company-level read

Ticker impact

$SJMNeutralMedium confidence
Context

Smucker guided FY27 coffee margin improvement into the high-20% range and assumed a 10% tariff level, with volume response to lower prices forecasted cautiously.

Expected impact

Moderate volatility risk around earnings expectations as traders reprice coffee margin timing (Q2+) and tariff/refund uncertainty.

Evidence & confidence

The article contains multiple concrete management outlook points (Q1 flat sales, Q2+ coffee deflation impact, Uncrustables mid-single-digit growth in FY27, marketing spend, and 10% tariff assumption) that can change consensus modeling, but it is still a call recap rather than a fresh filing.

Market effects

Signals how consumer-staples peers may manage commodity pass-through (coffee) and promotional discipline when consumers stay cautious.

Limited direct regional impact; mostly US retail/away-from-home channel mix commentary.

Tariff assumption and coffee commodity deflation timing can influence broader global input-cost narratives for packaged foods.

Counterpoint

High-20% retail coffee margin improvement is framed as a second-through-fourth-quarter event, so near-term upside may be muted if volume elasticity disappoints.

Key entities

  • J. M. Smucker

    Guided FY27 coffee margin improvement timing, Uncrustables growth outlook, marketing spend, tariff assumptions, and debt reduction/leverage target.

Related articles

$UTZMed

Family-owned companies have big appetites for US snack M&A

Utz UTZ.N agreed to be taken private by Germany’s Intersnack Group, with Utz’s founding families, in a deal valued at nearly $3 billion, the first U.S. acquisition for Intersnack. The article cites other family-led snack deals including Ferrero’s purchases of WK Kellogg and Power Crunch, and Mars’s $36 billion take-private of Kellanova. It notes valuation multiples and potential targets.

$SJMMedAI 9/10

Uncrustables tops $1 billion as JM Smucker posts strong Q4

JM Smucker said its Uncrustables brand surpassed $1 billion in annual sales in Q4, adding 3 million new households over the past year. The company reported Q4 earnings of $2.77 per share on $2.27 billion revenue, beating estimates of $2.65 on $2.27 billion, and shares rose over 10% after hours to $112.98. Smucker cited growth in Café Bustelo and pet brands.

$MRVLMed

Stocks Erase Early Gains as Chipmakers Turn Lower

US stocks pared early gains as chipmakers and software firms fell. Marvell, Qualcomm, ARM and others dropped, while ServiceNow and Salesforce also declined. Treasury yields were pressured by a $58B 3-year auction and stronger May existing home sales. In Europe, Bund and gilt yields fell; swaps price a 100% chance of a 25 bp ECB hike. UNFI slid after Q3 sales missed; Nuvalent surged on a $10.6B GSK buyout.

$SJMMedAI 8/10

Why J.M. Smucker Stock Jumped Today

J.M. Smucker shares rose Tuesday after the company reported fiscal 2026 Q4 results that beat Wall Street. Net sales grew 6% to $2.3B, helped by price increases offsetting volume declines. Adjusted EPS rose 20% to $2.77 vs. $2.64 expected; adjusted operating income rose 14% to $59.7M. Free cash flow increased 42% to $1.2B.

$MUMed

More swings for AI stocks drag Wall Street back on the roller coaster

Wall Street swung as AI-related chip and memory stocks reversed after early gains. The S&P 500 fell 0.3% (7,386.65), the Nasdaq dropped 1% (25,678.82), and the Dow rose 0.2% (50,872.11). Micron slid 1.4% after a 10% drop; it had surged 9.9% Monday. Oil eased (Brent -3% to $91.45) but AI weakness outweighed. GSK agreed to buy Nuvalent for $10.6B, sending Nuvalent up 39.3%.